Introducing GPT-Rosalind for life sciences research
OpenAI Blog
OpenAI released GPT-Rosalind, a reasoning model designed to assist with drug discovery, genomics analysis, and protein research tasks. The model applies advanced reasoning capabilities to scientific workflows that typically require extensive computational analysis and expert interpretation. Researchers in life sciences can now use GPT-Rosalind to process complex biological data more efficiently than previous general-purpose AI systems.
Why it matters
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.